Stable transduction of the neonatal mouse liver using a hybrid rAAV/sleeping beauty transposon gene delivery system.
Sharon C CunninghamPhilip M ZakasNatsuki SasakiEva B van DijkErhua ZhuYanfang FuWilliam E SalomonRobert J CitorikJacob R RubensCecilia Cotta-RamusinoWilliam QuerbesIan E AlexanderPublished in: The journal of gene medicine (2024)
The present study demonstrates the first in vivo utility of a hybrid rAAV/SB100X transposon system to achieve stable long-term therapeutic gene expression following delivery to the highly proliferative newborn mouse liver. These results have relevance to the treatment of genetic metabolic liver diseases with neonatal onset.